Nabih Naim
Overview
Explore the profile of Nabih Naim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zouein J, Naim N, Spencer D, Ortel T
Autoimmun Rev
. 2024 Dec;
24(2):103712.
PMID: 39617250
Background: Numerous genes have been associated with APS in the literature. In recent years, microRNA (miRNA) and long non-coding RNA (lncRNA) have also been shown to modulate the expression of...
2.
Kourie H, Mahrous M, Naim N, Zouein J, Benbrahim Z, Rasul K, et al.
Future Oncol
. 2023 Aug;
19(21):1451-1459.
PMID: 37526151
Gastric cancer (GC) ranks as the fifth most prevalent cancer and the fourth deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, GC represents about 4.8% of...
3.
Abi-Aad S, Zouein J, Chartouni A, Naim N, Kourie H
Immunotherapy
. 2023 Apr;
15(8):611-618.
PMID: 37009648
Immunotherapy has improved the prognosis of many cancers, yet a large number of patients have demonstrated resistance to current immune checkpoint inhibitors. LAG-3 is an immune checkpoint expressed on tumor-infiltrating...
4.
Zouein J, Naim N, Kourie H
Immunotherapy
. 2023 Jan;
15(2):93-100.
PMID: 36601860
Locoregional, as well as metastatic renal cell carcinoma, tends to relapse after nephrectomy or metastasectomy. Adjuvant therapy seems to be an effective strategy to reduce the risk of recurrence. All ...
5.
Kourie H, Ibnshamsah F, Zouein J, Naim N, Abbasi S, Allahloubi N, et al.
Future Oncol
. 2022 Jul;
18(24):2733-2744.
PMID: 35791837
Colorectal cancer (CRC) is ranked as the third most prevalent and the second deadliest cancer worldwide. In the Middle East and North Africa (MENA) region, the number of CRC cases...
6.
Naim N, Moukheiber S, Daou S, Kourie H
Crit Rev Oncol Hematol
. 2021 Nov;
168:103524.
PMID: 34800654
RAS is the most frequently mutated oncogene in human cancer. Scientists attempted for decades to target this protein or its pathways, however, all the attempts failed and RAS was labeled...
7.
Naim N, Moukheiber S, Jaber K, Kourie H
Per Med
. 2021 Oct;
18(6):523-525.
PMID: 34657456
No abstract available.